coopervision lteye delay annual meeting coopervision delay annual meeting june 22 14 board review recapitalization option meeting coopervision today report quarter net income 646 mln dlrs 1752 mln dlr pretax gain sale ophthalmic business johnson johnson ltjnj 260 mln dlrs cash 179 mln dlr posttax charge debt repurchase sale 944 mln dlrs year early earn 7300000 dlrs 120000 dlr loss discontinue operation sale 854 mln dlrs company aggressive program investment spending maintain increase market share core business accelerate sale growth year hold back increase operate income future coopervision furthermore entire net cash proceed recent sale business employ reduce indebtedness make strategic acquisition andor employ relation recapitalization company recovery net income hold back loss tax income ophthalmic pharmaceutical business sell johnson johnson